Loading…
Legislative Progress
Introduced
March 10, 2025
Latest Action
March 10, 2025
Primary Sponsor
Mariannette Miller-MeeksRepublican(IA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
DMEPOS Relief Act of 2025 This bill extends until December 31, 2025, a higher payment rate (known as the 75/25 blended rate) for durable medical equipment in nonrural or noncontiguous areas under Medicare.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (12)
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Health Issues
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medicare/Medicaid
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Medicare/Medicaid
Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Health Issues
Support DMEPOS Relief / Competitive Bidding Fix (S.2951/ H.R.2005)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medicare/Medicaid
Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding, including S. 4037, the DIABETES Act. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247 / H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare oxygen therapy services, including H.R. 2902 / S. 1406, the SOAR Act. Issues related to regulatory relief and program integrity.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
| Republican |
| NY |
| Daniel Meuser | Republican | PA |
| David Kustoff | Republican | TN |
| Diana Harshbarger | Republican | TN |
| Earl L. "Buddy" Carter | Republican | GA |
| Frank J. Mrvan | Democratic | IN |
| Glenn Thompson | Republican | PA |
| Jack Bergman | Republican | MI |
| Jimmy Panetta | Democratic | CA |
| John James | Republican | MI |
| Mark B. Messmer | Republican | IN |
| Mike Bost | Republican | IL |
| Nicholas A. Langworthy | Republican | NY |
| Paul Tonko | Democratic | NY |
| Randy Feenstra | Republican | IA |
| Robert B. Aderholt | Republican | AL |
| Ronny Jackson | Republican | TX |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Seth Moulton | Democratic | MA |
| Terri A. Sewell | Democratic | AL |
| Tim Walberg | Republican | MI |
| Zachary Nunn | Republican | IA |
2026 · third_quarter · Medicare/Medicaid
Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005 - DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.
Client expense: $390,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2026 · third_quarter · Medicare/Medicaid
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $200,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Support DMEPOS Relief / Competitive Bidding Fix (S.2951/ H.R.2005)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
H.R.5269/S.2761, the RESULTS Act. H.R.2005, the DMEPOS Relief Act. H.R.2902, the SOAR Act. H.R.5454/S.2879, Medicare Advantage Prompt Pay Act. H.R.6280/S.3607, the Access to Genetic Counselor Services Act. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act. Issues related to implementation of healthcare provisions in H.R.1. Issues related to CMS telehealth policies. Issues related to hospital outpatient reimbursement. Issues related to the Medicare area wage index. Issues related to Medicare Advantage. Issues related to Medicare GME. Issues related to Medicaid.
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)
Client expense: $400,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2026 · second_quarter · Medicare/Medicaid
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas; support of H.R.2005, DMEPOS Relief Act of 2025, issues related to CMS CY 2026 Home Health and Durable Medical Equipment, Prosthetics, Orthotics & Supplies (DMEPOS) Final Rule.
Client expense: Not reported · Firm income: $55,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding, including S. 4037, the DIABETES Act. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247 / H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare oxygen therapy services, including H.R. 2902 / S. 1406, the SOAR Act. Issues related to regulatory relief and program integrity.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005 - DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Medicare/Medicaid
Lobbied in favor of HR 2005 - Medicare reimbursement expansion Lobbied in favor of S 247 & HR 1703 - access to titanium and carbon fiber wheelchairs Lobbied in favor of S 4037 - the Diabetes Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Support DMEPOS Relief / Competitive Bidding Fix (S.2951/ H.R.2005)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
H.R.5269, the RESULTS Act. H.R.2005, the DMEPOS Relief Act. H.R.2902, the SOAR Act. H.R.5454/S.2879, Medicare Advantage Prompt Pay Act. H.R.6280/S.3607, the Access to Genetic Counselor Services Act. H.R.3514/S.1816, Improving Seniors Timely Access to Care Act. Issues related to implementation of healthcare provisions in H.R.1. Issues related to CMS telehealth policies. Issues related to hospital outpatient reimbursement. Issues related to the Medicare area wage index. Issues related to Medicare Advantage. Issues related to Medicare GME. Issues related to Medicaid.
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels. Issues related to continuous glucose monitors.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas; support of H.R.2005, DMEPOS Relief Act of 2025, issues related to CMS CY 2026 Home Health and Durable Medical Equipment, Prosthetics, Orthotics & Supplies (DMEPOS) Final Rule.
Client expense: Not reported · Firm income: $55,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.
Client expense: $480,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Client expense: $280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding, including S. 4037, the DIABETES Act. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247 / H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare oxygen therapy services, including H.R. 2902 / S. 1406, the SOAR Act. Issues related to regulatory relief and program integrity.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S.1406 - SOAR Act of 2025; Issues related to S.4037 Diabetes Act.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · fourth_quarter · Health Issues
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Medicare/Medicaid
Medicare NCD on access to power standing systems; Prior authorization reforms to speed access for people with serious disabilities; Service and repair reforms in health programs; HR 5081, Telehealth Modernization Act; HR 2005, DMEPOS Relief Act of 2025; HR 1703 Choices for Increased Mobility Act of 2025
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Medicare/Medicaid
Issues related to competitive bidding for home medical equipment; patient access to respiratory therapy including non-invasive ventilation and related reimbursement; DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); and promoting electronic prescribing platforms.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2025 · fourth_quarter · Health Issues
Support DMEPOS Relief / Competitive Bidding Fix (S.2951/ H.R.2005)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Medicare/Medicaid
Issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas; issues related to catheter reimbursement coding; issues related to non-invasive ventilator reimbursement; support of H.R.2005, DMEPOS Relief Act of 2025, issues related to CMS CY 2026 Home Health and Durable Medical Equipment, Prosthetics, Orthotics & Supplies (DMEPOS) Final Rule.
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Medicare/Medicaid
Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE
2025 · fourth_quarter · Medicare/Medicaid
Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S.1406 - SOAR Act of 2025.
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2025 · fourth_quarter · Medicare/Medicaid
Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247/H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare oxygen therapy services. Issues related to regulatory relief and program integrity.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2025 · fourth_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - A bill to direct the Secretary of Health and Human Services to provide for certain adjustments to Medicare payment for items of durable medical equipment that were formerly included in round 2021 of the DMEPOS competitive bidding program (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; H.R. 2902/S.1406 - The SOAR Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · third_quarter · Health Issues
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Support DMEPOS Relief / Competitive Bidding Fix (S.2951/ H.R.2005)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Medicare/Medicaid
Issues related to competitive bidding for home medical equipment; patient access to respiratory therapy including non-invasive ventilation and related reimbursement; DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); and promoting electronic prescribing platforms.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2025 · third_quarter · Medicare/Medicaid
Issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas; issues related to catheter reimbursement coding; issues related to non-invasive ventilator reimbursement; support of H.R.2005, DMEPOS Relief Act of 2025, issues related to CMS CY 2026 Home Health and Durable Medical Equipment, Prosthetics, Orthotics & Supplies (DMEPOS) Proposed Rule.
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - A bill to direct the Secretary of Health and Human Services to provide for certain adjustments to Medicare payment for items of durable medical equipment that were formerly included in round 2021 of the DMEPOS competitive bidding program (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025.
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2025 · third_quarter · Medicare/Medicaid
Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247/H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare coverage of non-invasive ventilators. Issues related to regulatory relief and program integrity.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2025 · third_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005/S.2951- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · second_quarter · Medicare/Medicaid
Issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas; issues related to catheter reimbursement coding; issues related to non-invasive ventilator reimbursement; support of H.R.2005, DMEPOS Relief Act of 2025.
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Medicare/Medicaid
HR2005 - 75/25 blended rule rate - we wanted these to remain in effect.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Health Issues
Issues related to the home healthcare equipment market. Issues related to CMS and DME rulemaking. Issues related to competitive bidding reform. Issues related to including non-invasive ventilators in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) competitive acquisition program. Issues related to audits imposed on the home healthcare equipment industry. Issues related to S. 1406 & H.R. 2902, the Supplemental Oxygen Access Reform (SOAR) Act. Issues related to creating an electronic template for the Durable Medical Equipment (DME) industry. Issues related to H.R. 2005, the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Relief Act of 2025.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Medicare/Medicaid
Issues related to competitive bidding for home medical equipment; patient access to respiratory therapy including non-invasive ventilation and related reimbursement; DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); and promoting electronic prescribing platforms.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Medicare/Medicaid
Issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas; issues related to catheter reimbursement coding; issues related to non-invasive ventilator reimbursement; support of H.R.2005, DMEPOS Relief Act of 2025.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Medicare/Medicaid
Issues pertaining to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025.
Client expense: $290,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE